Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 5UU9 | P00800 | Tetragonal thermolysin cryocooled to 100 K with 40% xylose as cryoprotectant | |
| 5UUA | P00800 | Tetragonal thermolysin cryocooled to 100 K with 50% xylose as cryoprotectant | |
| 5UUB | P00800 | Tetragonal thermolysin cryocooled to 100 K with 25% xylose/25% mpd as cryoprotectant | |
| 6D5N | P00800 | Hexagonal thermolysin (295) in the presence of 50% xylose | |
| 6N4Z | P00800 | Tetragonal thermolysin (with 50% xylose) plunge cooled in liquid nitrogen to 77 K | |
| 3FXP | P00800 | Thermolysin inhibition | |
| 2ASI | P00799 | ASPARTIC PROTEINASE | |
| 2RMP | P00799 | RMP-pepstatin A complex | |
| 1APT | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION | |
| 1APU | P00798 | Crystallographic analysis of a pepstatin analogue binding to the aspartyl proteinase penicillopepsin at 1.8 angstroms resolution | |
| 1APV | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH A TETRAHEDRAL TRANSITION STATE MIMIC INHIBITOR: ISOVALERYL (IVA)-VAL-VAL-HYDRATED DIFLUOROSTATONE-N-METHYLAMINE |
| 1APW | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH A TETRAHEDRAL TRANSITION STATE MIMIC INHIBITOR: ISOVALERYL (IVA)-VAL-VAL-DIFLUOROSTATINE-N-METHYLAMINE |
| 1BXO | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL CYCLO[(2S)-2-[[(1R)-1-(N-(L-N-(3-METHYLBUTANOYL)VALYL-L-ASPARTYL)AMINO)-3-METHYLBUT YL] HYDROXYPHOSPHINYLOXY]-3-(3-AMINOMETHYL) PHENYLPROPANOATE | |
| 1BXQ | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR. | |
| 1PPK | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHOROUS-CONTAINING PEPTIDE ANALOGUES | |
| 1PPL | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES | |
| 1PPM | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES | |
| 2WEA | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT | |
| 2WEB | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L-VALYL)AMINO-2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT | |
| 2WEC | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1-NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT | |
| 2WED | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT | |
| 5V8V | P00797 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | |
| 5TMG | P00797 | Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | |
| 5TMK | P00797 | Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | |
| 5SXN | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | |
| 5SY2 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | |
| 5SY3 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | |
| 5SZ9 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | |
| 5T4S | P00797 | Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors | |
| 5VPM | P00797 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | |
| 5VRP | P00797 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | |
| 6I3F | P00797 | Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom | |
| 1HRN | P00797 | HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS | |
| 1RNE | P00797 | THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR | |
| 2G1N | P00797 | Ketopiperazine-based renin inhibitors: Optimization of the "C" ring | |
| 2G1O | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | |
| 2G1R | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring | |
| 2G1S | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring | |
| 2G1Y | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | |
| 2G22 | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | |
| 2REN | P00797 | STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION | |
| 2V0Z | P00797 | Crystal Structure of Renin with Inhibitor 10 (Aliskiren) | |
| 3G6Z | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | |
| 3G70 | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | |
| 3G72 | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | |
| 3GW5 | P00797 | Crystal structure of human renin complexed with a novel inhibitor | |
| 3K1W | P00797 | New Classes of Potent and Bioavailable Human Renin Inhibitors | |
| 3KM4 | P00797 | Optimization of Orally Bioavailable Alkyl Amine Renin Inhibitors | |
| 3O9L | P00797 | Design and optimisation of new piperidines as renin inhibitors | |
| 3OAD | P00797 | Design and optimization of new piperidines as renin inhibitors |
